In vitro toxicity evaluation in the development of new anticancer drugs—genistein glycosides
To access this article, please choose from the options below
PII: S0304-3835(05)00069-8
doi:10.1016/j.canlet.2005.01.014
© 2005 Elsevier Ireland Ltd. All rights reserved.
